Rakel Óttarsdóttir
Technik-/Wissenschafts-/F&E-Leiter bei ICELANDAIR GROUP HF.
Profil
Rakel Óttarsdóttir is currently the Chief Digital Officer at Icelandair Group hf.
Prior to this, she worked as the Managing Director-Information Technology at Arion Banki HF from 2016 to 2019, and as Vice President at Össur hf.
In 2020, she became the Chief Information Officer at Alvotech hf, where she worked until 2022.
Ms. Óttarsdóttir holds an MBA from Duke University, which she received in 2002, and an undergraduate degree from the University of Iceland, which she received in 1997.
Aktive Positionen von Rakel Óttarsdóttir
Unternehmen | Position | Beginn |
---|---|---|
ICELANDAIR GROUP HF. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Rakel Óttarsdóttir
Unternehmen | Position | Ende |
---|---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2022 |
ARION BANKI HF. | Technik-/Wissenschafts-/F&E-Leiter | 20.09.2019 |
EMBLA MEDICAL HF. | Corporate Officer/Principal | - |
Ausbildung von Rakel Óttarsdóttir
University of Iceland | Undergraduate Degree |
Duke University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ARION BANKI HF. | Finance |
ICELANDAIR GROUP HF. | Transportation |
EMBLA MEDICAL HF. | Health Technology |
Private Unternehmen | 1 |
---|---|
Alvotech hf
Alvotech hf Pharmaceuticals: MajorHealth Technology Alvotech hf operates as a biotech company. It is focused on the development and manufacture of biosimilar medicines for patients. The company’s products help in treating autoimmune disorders, eye disorders, osteoporosis, respiratory disease, and cancer. Alvotech was founded by Robert Wessman in 2013 and is headquartered in Reykjavík, Iceland. | Health Technology |